Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: results from the SIOP-WT-2001 Registry.
Journal article published in 2018 by
Raquel Dávila Fajardo 
,
Eva Oldenburger,
Christian Rübe,
Marta López-Yurda,
Kathy Pritchard-Jones,
Christophe Bergeron,
Norbert Graf,
Martine van Grotel ,
Harm van Tinteren ,
Daniel Saunders,
Marry M. van den Heuvel-Eibrink,
Geert O. Janssens,
Foppe Oldenburger
,
Eva Oldenburger,
Christian Rübe,
Marta López-Yurda,
Kathy Pritchard-Jones,
Christophe Bergeron,
Norbert Graf,
Martine van Grotel ,
Harm van Tinteren ,
Daniel Saunders,
Marry M. van den Heuvel-Eibrink,
Geert O. Janssens,
Foppe Oldenburger
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
To evaluate the value of radiotherapy boost omission in patients with intermediate-risk, stage III Wilms tumours (WT) with positive lymph nodes (LN).